EverSource Wealth Advisors’s Soleno Therapeutics SLNO Stock Holding History

EverSource Wealth Advisors’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-301	Closed	-$10.1K	–	4528
2026 Q1	$10.1K	Buy	301 +192	+176%	+$7.53K	﹤0.01%	2917
2025 Q4	$5.05K	Sell	109 -27	-20%	-$1.48K	﹤0.01%	3115
2025 Q3	$9.19K	Buy	136 +35	+35%	+$2.6K	﹤0.01%	2870
2025 Q2	$8.46K	Buy	101 +93	+1,163%	+$6.96K	﹤0.01%	2913
2025 Q1	$572	Buy	+8	New	+$390	﹤0.01%	3410

EverSource Wealth Advisors's SLNO Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 301 shares — an estimated $10.1K sold.

EverSource Wealth Advisors first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $10.1K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

EverSource Wealth Advisors reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 301 Soleno Therapeutics shares in Q2 2026, an estimated $10.1K.
EverSource Wealth Advisors first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
EverSource Wealth Advisors's Soleno Therapeutics position peaked at $10.1K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.